U.S. DOD/CDMRP: Peer Reviewed Medical Research Program (PRMRP) LOI

16/07/2026

U.S. DOD/CDMRP: Peer Reviewed Medical Research Program (PRMRP) LOI

Description:

Accelerated Aging Processes Associated with Military Service | Angelman Syndrome | Burn Pit Exposure | Brain Injury Impact on Cardiac Health | Celiac Disease | Congenital Cytomegalovirus | Dystonia | Eating Disorders | Eczema | Ehlers-Danlos Syndrome | Endometriosis | Facioscapulohumeral Muscular Dystrophy | Fibrous Dysplasia/McCune-Albright Syndrome | Food Allergies | Fragile X | Frontotemporal Degeneration | Gambling Addiction | Hepatitis B | Hereditary and Acquired Ataxia | Hereditary Hemorrhagic Telangiectasia | Hermansky-Pudlak Syndrome | Hydrocephalus | Hypertrophic Dyschromia | Hypoxia | Infertility Associated with Military Aviators and Aviation Support Personnel | Inflammatory Bowel Disease | Interstitial Cystitis | Intranasal Ketamine Anesthetics | Maternal Mental Health | Mitochondrial Disease | Musculoskeletal Health | Myalgic Encephalomyelitis/Chronic Fatigue Syndrome | Myotonic Dystrophy | Orthotics and Prosthetics Outcomes | Pancreatitis | Pediatric Acute-Onset Neuropsychiatric Syndrome and Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcus | Peripheral Neuropathy | Polycystic Kidney Disease | Post-Traumatic Stress Disorder | Prader-Willi Syndrome | Proteomics | Pulmonary Fibrosis | Respiratory Health | Rett Syndrome | Sarcoidosis | Scleroderma | Sickle-Cell Disease | Sleep Disorders and Restriction | Spinal Muscular Atrophy | Suicide Prevention | Tuberculosis | von Hippel-Lindau Syndrome

Discovery Award: Supports innovative, untested, non-incremental, high-risk/potentially high-reward research that will provide new insights, paradigms, technologies, or applications with impact on one of the FY26 PRMRP topic areas and one of the FY26 PRMRP strategic goals.

Funding: up to $385K for 2 years.

Research Advancement Award: Supports fundamental research studies that will make an important contribution towards research, patient care, and/or quality of life for a disease or condition related to one of the FY26 PRMRP topic areas and one of the FY26 PRMRP strategic goals.

Funding: up to $1.4M for 4 years.

https://ebrap.org/eBRAP/public/ProgramFY.htm?programFYId=719111

https://ebrap.org/eBRAP/public/Program.htm

 

 

 

Fields :

  • Life Sciences

Source :

Foreign

© All rights reserved 2024